 | • レポートコード：QFJ1-5631 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、骨転移の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、骨形成薬、標的療法剤）、用途別市場規模（病院、がんリハビリセンター、専門クリニック、外来外科センター）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・骨転移の市場動向 ・企業の競争状況、市場シェア ・骨転移の種類別市場規模と予測2016-2027（鎮痛剤、骨形成薬、標的療法剤） ・骨転移の用途別市場規模と予測2016-2027（病院、がんリハビリセンター、専門クリニック、外来外科センター） ・骨転移の北米市場規模2016-2027（アメリカ、カナダ） ・骨転移の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・骨転移のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・骨転移の中南米市場規模2016-2027（メキシコ、ブラジル） ・骨転移の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Bayer、Merck & Co、Pfizer、Novartis、Amgen、Pharmalucence、Fresenius Kabi、Omega Laboratories、Eli Lilly and Company） ・結論 |
Bone metastases, or osseous metastatic disease, is a category of cancer metastases that results from primary tumor invasion to bone. Bone-originating primary tumors such as osteosarcoma, chondrosarcoma, and Ewing’s sarcoma are rare.
Market Analysis and Insights: Global Bone Metastasis Market
The global Bone Metastasis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bone Metastasis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bone Metastasis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bone Metastasis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bone Metastasis market.
Global Bone Metastasis Scope and Market Size
Bone Metastasis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bone Metastasis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pain Relievers
Bone Building Medications
Targeted Therapy Agents
Segment by Application
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Bayer
Merck & Co
Pfizer
Novartis
Amgen
Pharmalucence
Fresenius Kabi
Omega Laboratories
Eli Lilly and Company
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bone Metastasis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pain Relievers
1.2.3 Bone Building Medications
1.2.4 Targeted Therapy Agents
1.3 Market by Application
1.3.1 Global Bone Metastasis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Rehabilitation Centers
1.3.4 Specialty Clinics
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bone Metastasis Market Perspective (2016-2027)
2.2 Bone Metastasis Growth Trends by Regions
2.2.1 Bone Metastasis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bone Metastasis Historic Market Share by Regions (2016-2021)
2.2.3 Bone Metastasis Forecasted Market Size by Regions (2022-2027)
2.3 Bone Metastasis Industry Dynamic
2.3.1 Bone Metastasis Market Trends
2.3.2 Bone Metastasis Market Drivers
2.3.3 Bone Metastasis Market Challenges
2.3.4 Bone Metastasis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bone Metastasis Players by Revenue
3.1.1 Global Top Bone Metastasis Players by Revenue (2016-2021)
3.1.2 Global Bone Metastasis Revenue Market Share by Players (2016-2021)
3.2 Global Bone Metastasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bone Metastasis Revenue
3.4 Global Bone Metastasis Market Concentration Ratio
3.4.1 Global Bone Metastasis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bone Metastasis Revenue in 2020
3.5 Bone Metastasis Key Players Head office and Area Served
3.6 Key Players Bone Metastasis Product Solution and Service
3.7 Date of Enter into Bone Metastasis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bone Metastasis Breakdown Data by Type
4.1 Global Bone Metastasis Historic Market Size by Type (2016-2021)
4.2 Global Bone Metastasis Forecasted Market Size by Type (2022-2027)
5 Bone Metastasis Breakdown Data by Application
5.1 Global Bone Metastasis Historic Market Size by Application (2016-2021)
5.2 Global Bone Metastasis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bone Metastasis Market Size (2016-2027)
6.2 North America Bone Metastasis Market Size by Type
6.2.1 North America Bone Metastasis Market Size by Type (2016-2021)
6.2.2 North America Bone Metastasis Market Size by Type (2022-2027)
6.2.3 North America Bone Metastasis Market Size by Type (2016-2027)
6.3 North America Bone Metastasis Market Size by Application
6.3.1 North America Bone Metastasis Market Size by Application (2016-2021)
6.3.2 North America Bone Metastasis Market Size by Application (2022-2027)
6.3.3 North America Bone Metastasis Market Size by Application (2016-2027)
6.4 North America Bone Metastasis Market Size by Country
6.4.1 North America Bone Metastasis Market Size by Country (2016-2021)
6.4.2 North America Bone Metastasis Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bone Metastasis Market Size (2016-2027)
7.2 Europe Bone Metastasis Market Size by Type
7.2.1 Europe Bone Metastasis Market Size by Type (2016-2021)
7.2.2 Europe Bone Metastasis Market Size by Type (2022-2027)
7.2.3 Europe Bone Metastasis Market Size by Type (2016-2027)
7.3 Europe Bone Metastasis Market Size by Application
7.3.1 Europe Bone Metastasis Market Size by Application (2016-2021)
7.3.2 Europe Bone Metastasis Market Size by Application (2022-2027)
7.3.3 Europe Bone Metastasis Market Size by Application (2016-2027)
7.4 Europe Bone Metastasis Market Size by Country
7.4.1 Europe Bone Metastasis Market Size by Country (2016-2021)
7.4.2 Europe Bone Metastasis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bone Metastasis Market Size (2016-2027)
8.2 Asia-Pacific Bone Metastasis Market Size by Type
8.2.1 Asia-Pacific Bone Metastasis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bone Metastasis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bone Metastasis Market Size by Type (2016-2027)
8.3 Asia-Pacific Bone Metastasis Market Size by Application
8.3.1 Asia-Pacific Bone Metastasis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bone Metastasis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bone Metastasis Market Size by Application (2016-2027)
8.4 Asia-Pacific Bone Metastasis Market Size by Region
8.4.1 Asia-Pacific Bone Metastasis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bone Metastasis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bone Metastasis Market Size (2016-2027)
9.2 Latin America Bone Metastasis Market Size by Type
9.2.1 Latin America Bone Metastasis Market Size by Type (2016-2021)
9.2.2 Latin America Bone Metastasis Market Size by Type (2022-2027)
9.2.3 Latin America Bone Metastasis Market Size by Type (2016-2027)
9.3 Latin America Bone Metastasis Market Size by Application
9.3.1 Latin America Bone Metastasis Market Size by Application (2016-2021)
9.3.2 Latin America Bone Metastasis Market Size by Application (2022-2027)
9.3.3 Latin America Bone Metastasis Market Size by Application (2016-2027)
9.4 Latin America Bone Metastasis Market Size by Country
9.4.1 Latin America Bone Metastasis Market Size by Country (2016-2021)
9.4.2 Latin America Bone Metastasis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bone Metastasis Market Size (2016-2027)
10.2 Middle East & Africa Bone Metastasis Market Size by Type
10.2.1 Middle East & Africa Bone Metastasis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bone Metastasis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bone Metastasis Market Size by Type (2016-2027)
10.3 Middle East & Africa Bone Metastasis Market Size by Application
10.3.1 Middle East & Africa Bone Metastasis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bone Metastasis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bone Metastasis Market Size by Application (2016-2027)
10.4 Middle East & Africa Bone Metastasis Market Size by Country
10.4.1 Middle East & Africa Bone Metastasis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bone Metastasis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Bone Metastasis Introduction
11.1.4 Roche Revenue in Bone Metastasis Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Bone Metastasis Introduction
11.2.4 Bayer Revenue in Bone Metastasis Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview
11.3.3 Merck & Co Bone Metastasis Introduction
11.3.4 Merck & Co Revenue in Bone Metastasis Business (2016-2021)
11.3.5 Merck & Co Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bone Metastasis Introduction
11.4.4 Pfizer Revenue in Bone Metastasis Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Bone Metastasis Introduction
11.5.4 Novartis Revenue in Bone Metastasis Business (2016-2021)
11.5.5 Novartis Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Bone Metastasis Introduction
11.6.4 Amgen Revenue in Bone Metastasis Business (2016-2021)
11.6.5 Amgen Recent Development
11.7 Pharmalucence
11.7.1 Pharmalucence Company Details
11.7.2 Pharmalucence Business Overview
11.7.3 Pharmalucence Bone Metastasis Introduction
11.7.4 Pharmalucence Revenue in Bone Metastasis Business (2016-2021)
11.7.5 Pharmalucence Recent Development
11.8 Fresenius Kabi
11.8.1 Fresenius Kabi Company Details
11.8.2 Fresenius Kabi Business Overview
11.8.3 Fresenius Kabi Bone Metastasis Introduction
11.8.4 Fresenius Kabi Revenue in Bone Metastasis Business (2016-2021)
11.8.5 Fresenius Kabi Recent Development
11.9 Omega Laboratories
11.9.1 Omega Laboratories Company Details
11.9.2 Omega Laboratories Business Overview
11.9.3 Omega Laboratories Bone Metastasis Introduction
11.9.4 Omega Laboratories Revenue in Bone Metastasis Business (2016-2021)
11.9.5 Omega Laboratories Recent Development
11.10 Eli Lilly and Company
11.10.1 Eli Lilly and Company Company Details
11.10.2 Eli Lilly and Company Business Overview
11.10.3 Eli Lilly and Company Bone Metastasis Introduction
11.10.4 Eli Lilly and Company Revenue in Bone Metastasis Business (2016-2021)
11.10.5 Eli Lilly and Company Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Bone Metastasis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pain Relievers
Table 3. Key Players of Bone Building Medications
Table 4. Key Players of Targeted Therapy Agents
Table 5. Global Bone Metastasis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Bone Metastasis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bone Metastasis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Bone Metastasis Market Share by Regions (2016-2021)
Table 9. Global Bone Metastasis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Bone Metastasis Market Share by Regions (2022-2027)
Table 11. Bone Metastasis Market Trends
Table 12. Bone Metastasis Market Drivers
Table 13. Bone Metastasis Market Challenges
Table 14. Bone Metastasis Market Restraints
Table 15. Global Bone Metastasis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Bone Metastasis Market Share by Players (2016-2021)
Table 17. Global Top Bone Metastasis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis as of 2020)
Table 18. Ranking of Global Top Bone Metastasis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Bone Metastasis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Bone Metastasis Product Solution and Service
Table 22. Date of Enter into Bone Metastasis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Bone Metastasis Revenue Market Share by Type (2016-2021)
Table 26. Global Bone Metastasis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Bone Metastasis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Bone Metastasis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Bone Metastasis Revenue Market Share by Application (2016-2021)
Table 30. Global Bone Metastasis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Bone Metastasis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Bone Metastasis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Bone Metastasis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Bone Metastasis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Bone Metastasis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Bone Metastasis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Bone Metastasis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Bone Metastasis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Bone Metastasis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Bone Metastasis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Bone Metastasis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Bone Metastasis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Bone Metastasis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Bone Metastasis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Bone Metastasis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Bone Metastasis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Bone Metastasis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Bone Metastasis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Bone Metastasis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Bone Metastasis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Bone Metastasis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Bone Metastasis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Bone Metastasis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Bone Metastasis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Bone Metastasis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Bone Metastasis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Bone Metastasis Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Bone Metastasis Product
Table 65. Roche Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Bayer Company Details
Table 68. Bayer Business Overview
Table 69. Bayer Bone Metastasis Product
Table 70. Bayer Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 71. Bayer Recent Development
Table 72. Merck & Co Company Details
Table 73. Merck & Co Business Overview
Table 74. Merck & Co Bone Metastasis Product
Table 75. Merck & Co Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 76. Merck & Co Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Bone Metastasis Product
Table 80. Pfizer Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Bone Metastasis Product
Table 85. Novartis Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Bone Metastasis Product
Table 90. Amgen Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Pharmalucence Company Details
Table 93. Pharmalucence Business Overview
Table 94. Pharmalucence Bone Metastasis Product
Table 95. Pharmalucence Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 96. Pharmalucence Recent Development
Table 97. Fresenius Kabi Company Details
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 100. Fresenius Kabi Recent Development
Table 101. Omega Laboratories Company Details
Table 102. Omega Laboratories Business Overview
Table 103. Omega Laboratories Bone Metastasis Product
Table 104. Omega Laboratories Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 105. Omega Laboratories Recent Development
Table 106. Eli Lilly and Company Company Details
Table 107. Eli Lilly and Company Business Overview
Table 108. Eli Lilly and Company Bone Metastasis Product
Table 109. Eli Lilly and Company Revenue in Bone Metastasis Business (2016-2021) & (US$ Million)
Table 110. Eli Lilly and Company Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bone Metastasis Market Share by Type: 2020 VS 2027
Figure 2. Pain Relievers Features
Figure 3. Bone Building Medications Features
Figure 4. Targeted Therapy Agents Features
Figure 5. Global Bone Metastasis Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Cancer Rehabilitation Centers Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Bone Metastasis Report Years Considered
Figure 11. Global Bone Metastasis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bone Metastasis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bone Metastasis Market Share by Regions: 2020 VS 2027
Figure 14. Global Bone Metastasis Market Share by Regions (2022-2027)
Figure 15. Global Bone Metastasis Market Share by Players in 2020
Figure 16. Global Top Bone Metastasis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bone Metastasis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bone Metastasis Revenue in 2020
Figure 18. Global Bone Metastasis Revenue Market Share by Type (2016-2021)
Figure 19. Global Bone Metastasis Revenue Market Share by Type (2022-2027)
Figure 20. North America Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bone Metastasis Market Share by Type (2016-2027)
Figure 22. North America Bone Metastasis Market Share by Application (2016-2027)
Figure 23. North America Bone Metastasis Market Share by Country (2016-2027)
Figure 24. United States Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bone Metastasis Market Share by Type (2016-2027)
Figure 28. Europe Bone Metastasis Market Share by Application (2016-2027)
Figure 29. Europe Bone Metastasis Market Share by Country (2016-2027)
Figure 30. Germany Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bone Metastasis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bone Metastasis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bone Metastasis Market Share by Region (2016-2027)
Figure 40. China Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bone Metastasis Market Share by Type (2016-2027)
Figure 48. Latin America Bone Metastasis Market Share by Application (2016-2027)
Figure 49. Latin America Bone Metastasis Market Share by Country (2016-2027)
Figure 50. Mexico Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bone Metastasis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bone Metastasis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bone Metastasis Market Share by Country (2016-2027)
Figure 56. Turkey Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bone Metastasis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 61. Merck & Co Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 64. Amgen Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 65. Pharmalucence Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 66. Fresenius Kabi Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 67. Omega Laboratories Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 68. Eli Lilly and Company Revenue Growth Rate in Bone Metastasis Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の脳転移治療市場規模・現状・予測（2021年-2027年） Brain metastasis is a kind of cancer. Cancers that have spread to the brain include breast cancer, lung cancer, melanoma, renal cell carcinoma, etc. Brain metastases mostly occur in the brain, and can be effectively relieved by chemotherapy, radiation therapy and other treatment methods. Market Anal…- 世界の骨密度検査市場規模・現状・予測（2021年-2027年） Bone density testing provides more high-level overview and in-depth details on more specific aspects of bone health, and identifies current and potential health risks such as low bone density, osteoporosis, and hyperthyroidism. Market Analysis and Insights: Global Bone Density Testing Market The glo…
- 世界の転移性骨疾患市場規模・現状・予測（2021年-2027年） Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. Market Analysis and Insights: Global Metastatic Bone Disea…
- 世界の血液＆骨髄腫治療市場規模・現状・予測（2021年-2027年） Blood cancer begins in the bone marrow which is the integral source of stem cells which later are differentiated in different types of blood cells in the human body. Market Analysis and Insights: Global Blood and Bone Marrow Cancer Treatment Market The global Blood and Bone Marrow Cancer Treatment m…
- 世界の単房性骨嚢胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Unicameral Bone Cyst Treatment Market The global Unicameral Bone Cyst Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data int…